In an effort to maximize the earnings potential of its plaque psoriasis cream, Danish dermatology biotech MC2 Therapeutics ...

This transition reflects a planned and strategic evolution of MC2 Therapeutics, aligned with the company’s focus on commercial expansion.

As previously announced, Kathryn Leaf has assumed the role of Chief Executive Officer, while Jeff Miller is now Chief Investment Officer. Kathryn and Jeff both joined Pantheon in 2008, and most ...

Complete digital access to quality FT journalism with expert analysis from industry leaders. Pay a year upfront and save 20%.